Entering text into the input field will update the search result below

FDA OKs Grifols test for Babesia parasites in blood screening

Feb. 07, 2019 12:49 PM ETGrifols, S.A. (GIKLY) StockGIFLF, GRFSBy: Douglas W. House, SA News Editor
  • The FDA approves an assay developed by Grifols (OTCPK:GIKLY) used to screen donated blood for the presence of four species of malaria-like parasites called Babesia, transmitted by certain ticks. The highest number of infections in the U.S. occur in the Northeast, Wisconsin and Minnesota.
  • The test is performed on the automated Procleix Panther system.

Recommended For You

More Trending News

About GIKLY Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
GIKLY--
Grifols, S.A.